Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults With Mobility Limitations
Conditions
Interventions
BYM338
Placebo
Locations
5
United States
Novartis Investigative Site
Hot Springs, Arkansas, United States
Novartis Investigative Site
Little Rock, Arkansas, United States
Novartis Investigative Site
Miami, Florida, United States
Novartis Investigative Site
Miami, Florida, United States
Novartis Investigative Site
Brighton, Massachusetts, United States
Start Date
January 1, 2012
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
December 17, 2020
NCT06188767
NCT06475391
NCT06317116
NCT06810271
NCT04872998
NCT07142850
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions